Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Multiple Myeloma – Access & Reimbursement – Access & Reimbursement – Multiple Myeloma (US)
MARKET OUTLOOKSuccessive label expansions in the multiple myeloma treatment landscape are driving significant commercial reward for some well-entrenched current therapies. With Celgene’s Revlimid…
Immune (Idiopathic) Thrombocytopenic Purpura | Niche & Rare Disease Landscape & Forecast | US/EU5 | 2018
Immune thrombocytopenic purpura (ITP) is a hematological autoimmune disorder characterized by low platelet count in the blood, which may lead to easy bruising and bleeding. ITP has an acute,…